Edward Morrow Atkinson III, EVP and Chief Technical Operations Officer at Vertex Pharmaceuticals ($VRTX), sold about $3.6 million in company shares across five open market transactions over the past year. His most recent sale occurred on February 25, 2026. These sales rank him 2,399th among 11,678 individual insiders by total value sold, below the average of $8.6 million per insider and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1627 | $485.11 | 19,100.0000 | 258,000,000 | 7.85% | 0.00% |
| Feb. 25, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 668 | $486.35 | 18,432.0000 | 258,000,000 | 3.50% | 0.00% |
| Feb. 18, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 817 | $473.68 | 20,727.0000 | 258,000,000 | 3.79% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 4962 | $0.00 | 25,105.0000 | 258,000,000 | 24.63% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1530 | $483.75 | 23,575.0000 | 258,000,000 | 6.09% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 2031 | $489.46 | 21,544.0000 | 258,000,000 | 8.62% | 0.00% |
| Feb. 13, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1903 | $487.76 | 20,143.0000 | 258,000,000 | 8.63% | 0.00% |
| Feb. 11, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 1751 | $460.43 | 22,046.0000 | 258,000,000 | 7.36% | 0.00% |
| Feb. 10, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 872 | $468.41 | 23,797.0000 | 258,000,000 | 3.53% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 3934 | $0.00 | 20,786.0000 | 258,000,000 | 23.34% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 3883 | $0.00 | 24,669.0000 | 258,000,000 | 18.68% | 0.00% |
| Nov. 17, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 2500 | $434.58 | 16,852.0000 | 258,600,000 | 12.92% | 0.00% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | Atkinson Edward Morrow III | Not found | D | Stock Option (Right to Buy) | 27400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | Atkinson Edward Morrow III | Not found | D | Stock Option (Right to Buy) | 56400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | Atkinson Edward Morrow III | Not found | D | Stock Option (Right to Buy) | 45150 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | Atkinson Edward Morrow III | Not found | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Feb. 26, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 2482 | $479.61 | 22,002.0000 | 257,899,999 | 10.14% | 0.00% |
| Feb. 27, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 2650 | $475.34 | 19,352.0000 | 257,899,999 | 12.04% | 0.00% |
| Feb. 25, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 1767 | $480.95 | 24,484.0000 | 257,899,999 | 6.73% | 0.00% |
| Feb. 24, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1656 | $483.28 | 26,251.0000 | 257,899,999 | 5.93% | 0.00% |
| Feb. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1529 | $463.46 | 27,907.0000 | 257,899,999 | 5.19% | 0.00% |
| Feb. 12, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 6211 | $0.00 | 29,436.0000 | 257,899,999 | 26.74% | 0.00% |
| Feb. 11, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 1747 | $459.83 | 23,225.0000 | 257,899,999 | 7.00% | 0.00% |
| Feb. 10, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 876 | $467.98 | 24,972.0000 | 257,899,999 | 3.39% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 5132 | $0.00 | 21,104.0000 | 257,899,999 | 32.13% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 4744 | $0.00 | 25,848.0000 | 257,899,999 | 22.48% | 0.00% |
| Feb. 3, 2025 | 89bio, Inc. | $ETNB | Atkinson Edward Morrow III | Not found | A | Stock Option (Right to Buy) | 56400 | $0.00 | 56,400.0000 | 104,714,613 | 9999.99% | 0.05% |
| June 11, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 6824 | $481.96 | 23,260.0000 | 260,500,000 | 22.68% | 0.00% |
| June 12, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 7288 | $478.00 | 15,972.0000 | 260,500,000 | 31.33% | 0.00% |
| May 14, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 14112 | $0.00 | 30,084.0000 | 260,500,000 | 88.35% | 0.01% |
| Feb. 23, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1654 | $431.79 | 16,855.0000 | 260,500,000 | 8.94% | 0.00% |
| Feb. 26, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 883 | $425.70 | 15,972.0000 | 260,500,000 | 5.24% | 0.00% |
| Feb. 21, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 1201 | $421.77 | 18,509.0000 | 260,500,000 | 6.09% | 0.00% |
| Feb. 16, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1501 | $424.01 | 21,636.0000 | 260,500,000 | 6.49% | 0.00% |
| Feb. 20, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 801 | $420.79 | 19,710.0000 | 260,500,000 | 3.91% | 0.00% |
| Feb. 20, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 1125 | $420.58 | 20,511.0000 | 260,500,000 | 5.20% | 0.00% |
| Feb. 12, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S | Common Stock | 913 | $420.24 | 23,137.0000 | 260,500,000 | 3.80% | 0.00% |
| Feb. 9, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F | Common Stock | 832 | $422.74 | 24,050.0000 | 260,500,000 | 3.34% | 0.00% |
| Feb. 7, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 4743 | $0.00 | 24,882.0000 | 260,500,000 | 23.55% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 3934 | $0.00 | 20,139.0000 | 260,500,000 | 24.28% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | A | Common Stock | 2326 | $0.00 | 16,205.0000 | 260,500,000 | 16.76% | 0.00% |
| Feb. 1, 2024 | 89bio, Inc. | $ETNB | Atkinson Edward Morrow III | Not found | A | Stock Option (Right to Buy) | 45150 | $0.00 | 45,150.0000 | 71,172,870 | 9999.99% | 0.06% |
| June 1, 2023 | 89bio, Inc. | $ETNB | Atkinson Edward Morrow III | Not found | M | Stock Option (Right to Buy) | 6250 | $0.00 | 0.0000 | 34,806,349 | 100.00% | 0.02% |
| June 1, 2023 | 89bio, Inc. | $ETNB | Atkinson Edward Morrow III | Not found | S | Common Stock | 6250 | $17.91 | 0.0000 | 34,806,349 | 100.00% | 0.02% |
| June 1, 2023 | 89bio, Inc. | $ETNB | Atkinson Edward Morrow III | Not found | M | Common Stock | 6250 | $2.61 | 6,250.0000 | 34,806,349 | 9999.99% | 0.02% |
| March 1, 2023 | 89bio, Inc. | $ETNB | Atkinson Edward Morrow III | Director | M | Stock Option (Right to Buy) | 10000 | $0.00 | 20,000.0000 | 34,806,349 | 33.33% | 0.03% |
| March 1, 2023 | 89bio, Inc. | $ETNB | Atkinson Edward Morrow III | Director | S | Common Stock | 10000 | $13.60 | 0.0000 | 34,806,349 | 100.00% | 0.03% |
| March 1, 2023 | 89bio, Inc. | $ETNB | Atkinson Edward Morrow III | Director | M | Common Stock | 10000 | $4.44 | 10,000.0000 | 34,806,349 | 9999.99% | 0.03% |
| Feb. 9, 2023 | 89bio, Inc. | $ETNB | Atkinson Edward Morrow III | Director | A | Stock Option (Right to Buy) | 27400 | $0.00 | 27,400.0000 | 34,806,349 | 9999.99% | 0.08% |